News

In December last year the company also filed the CAR-T therapy with the FDA.

The extension is based on data from the Phase III TITAN study, which assessed the addition of the drug to androgen deprivation therapy in a broad range of patients with metastatic hormone-sensitive prostate cancer.

Lung cancer is one of the most prevalent forms of cancer and kills more women than breast and ovarian cancers combined.

The competition entries are open from Tuesday 28 January for the next five weeks, and companies can bid for a share of £140 million to launch their innovation across the health service.

A study found that the most innovative cancer drugs took 3.2 years longer to go from the filing of the patent through to NHS.

Backed by £14 million of investment, local health service and council teams will begin the roll out of the “Urgent Community Response” teams from April.

The drug recently received Accelerated Approval in the US for certain HER2-positive unresectable or metastatic breast cancer.

Patients were randomised within 24 hours of onset of acute ischaemic stroke or high-risk transient ischaemic attack symptoms and followed-up for 30 days of treatment.

The committee cited multiple uncertainties.

Obesity is very common in England, affecting about 26% of the adult population.

The money will go towards 14 new NIHR Health Protection Research Units (HPRUs).

Just last week NICE released a draft guidance not recommending the medicine for moderately to severely active ulcerative colitis in adults.

Reckitt Benckiser, VCCP and Teva were also successful on the night.

Starting in September 2015, UK infants were offered the meningitis B vaccine at two and four months old.